Current Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 23 Issue: 33
Author(s): Holger Stark
Affiliation:
Export Options
About this article
Cite this article as:
Stark Holger, Meet Our Editorial Board Member, Current Medicinal Chemistry 2016; 23 (33) . https://dx.doi.org/10.2174/092986732333161104191930
DOI https://dx.doi.org/10.2174/092986732333161104191930 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 2: Pharmacodynamic Modeling and Distribution on Ligand-Target Space of Effective Components
Letters in Drug Design & Discovery Editorial: Challenge for the European Union: Immigrant and Refugee Health
Inflammation & Allergy - Drug Targets (Discontinued) Therapies Targeting Inflammation After Stent Implantation
Current Vascular Pharmacology Editorial: [Hot topic: Recent Advances in Drug Intolerance (Guest Editors: Jose A.G. Agundez)]
Current Drug Metabolism Mesenchymal Stem Cells: Use in Cartilage Repair
Current Rheumatology Reviews Cannabinoids and Neuroprotection in Motor-Related Disorders
CNS & Neurological Disorders - Drug Targets Statins and Solid Organ Transplantation
Current Pharmaceutical Design Biomarkers of Subclinical Atherosclerosis and Natural Products as Complementary Alternative Medicine
Current Pharmaceutical Design Roles of Natural Compounds from Medicinal Plants in Cancer Treatment: Structure and Mode of Action at Molecular Level
Medicinal Chemistry Regulation of Innate Immune Responses in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Peroxisome Proliferator-Activated Receptor-γ in Vascular Biology
Cardiovascular & Hematological Disorders-Drug Targets Sarcopenia in Patients with Advanced Liver Disease
Current Protein & Peptide Science Cationic Lipid-DNA Complexes for Gene Therapy: Understanding the Relationship Between Complex Structure and Gene Delivery Pathways at the Molecular Level
Current Medicinal Chemistry Natural and Synthetic Coumarin Derivatives with Anti-Inflammatory / Antioxidant Activities
Current Pharmaceutical Design Humoral and Mechanical Cross-Talk in the Vasculature: Perspectives in Vascular Disease
Vascular Disease Prevention (Discontinued) Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
Current Molecular Medicine Biology and Impact of Signal Transducers and Activators of Transcription and Their Regulators as Targets in Cancer Therapy
Current Signal Transduction Therapy Tianeptine: A Novel Atypical Antidepressant that May Provide New Insights into the Biomolecular Basis of Depression
Recent Patents on CNS Drug Discovery (Discontinued) Editorial (Hot Topic Potential Value and Limitation of Dual Inhibitors of PI3K and mTOR in the Treatment of Cancer)
Current Cancer Drug Targets Antiviral Effects of Asian Natural Products Targeting SARS, MERS, and COVID-19
Coronaviruses